Table 4

Parameters predicting retrospective consent

Consent to treatment

OR (95% CI)

P value

Univariate analysis

Demographic data

Age

2.800 (0.350-5.808)

0.1057

Sex: female

3.407 (0.438-8.071)

0.1853

Mechanical ventilation

3.082 (0.414-22.923)

0.2716

Funct. status preadmission

1.263 (0.380-4.203)

0.7033

Diagnosis

Ischemia

0.440 (0.316-0.612)

<0.0001

ICH

0.441 (0.312-0.625)

<0.0001

SAH

1.408 (0.689-2.880)

0.3482

Meningoencephalitis

4.019 (1.908-8.470)

0.0003

Epilepsy

2.627 (1.581-4.363)

0.0002

GBS/MG

3.560 (1.313-9.650)

0.0126

Neurodeg./Encephalopathy

0.872 (0.764-1.031)

0.0219

Cerebral neoplasm

0.623 (0.453-0.824)

0.0038

Intoxication

1.259 (0.853-1.738)

0.6432

Functional status at 1 year

after discharge

mRS

0.588 (0.538-0.642)

<0.0001

Multivariate analysis

Ischemia

0.294 (0.169-0.509)

<0.0001

ICH

0.306 (0.173-0.541)

<0.0001

Meningoencephalitis

1.076 (0.426-2.721)

0.8764

Epilepsy

0.568 (0.274-1.179)

0.1289

GBS/MG

0.698 (0.218-2.230)

0.5426

Neurodeg./Encephalopathy

0.821 (0.691-1.368)

0.2574

Cerebral neoplasm

0.572 (0.378-0.911)

0.0097

mRS

0.610 (0.555-0.671)

<0.0001

Univariate and multivariate regression analysis to identify predisposing parameters for retrospective consent to neurocritical care. Parameters that reached significance (P < 0.01) are expressed in bold.

OR, odds ratio; CI, confidence interval; Funct, functional; ICH, intracranial hemorrhage; SAH; subarachnoid hemorrhage; GBS, Guillain-Barré syndrome; MG, myasthenia gravis; Neurodeg, neurodegenerative disease; mRS, modified Rankin Scale.

Kiphuth et al. Critical Care 2010 14:R144   doi:10.1186/cc9210